GENE ONLINE|News &
Opinion
Blog

Novartis
Novartis’ Generic-drugs Unit Partners with Samsung Bioepis for Biosimilar Drug Launch
2023-09-12
GeneOnline’s Weekly News Highlights: July 31-Aug 4
2023-08-07
Novartis Acquires DTx Pharma and Expands Its Neuroscience Pipeline
2023-07-20
GeneOnline’s Weekly News Highlights: June 12-16
2023-06-17
Novartis Plans to Acquire Chinook Therapeutics in a Potential $3.5B Deal, Revolutionizing IgAN Treatment Landscape
2023-06-14
Novartis Lays Down $40 Million for 3BP’s FAP-Targeting Oncology Tech
2023-04-24
Novartis’ CDK4/6 Inhibitor Meets Phase 3 Endpoints In Breast Cancer
2023-03-28
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
Clovis Offloads Cancer Candidate to Novartis, Day After Declaring Bankruptcy
2022-12-13
Novartis’ Pluvicto Continues Winning Streak In Prostate Cancer Indication
2022-12-07
Novartis Shifts Gear To Phase 3 For Anti-Malaria Drug
2022-11-24
Novartis Ordered to Pay $177.8 million to Plexxikon for Patent Infringements
2022-10-03
1 2 3 6
LATEST
Ginkgo Bioworks and Pfizer Forge $331 Million Collaboration for RNA-Based Drug Discovery
2023-09-29
Johnson & Johnson Partners with Singapore to Boost Life Sciences Innovation
2023-09-28
Vietnam and South Korea Strengthen Cooperation in Multiple Sectors
2023-09-27
PeptiDream and Genentech Collaborate on Novel Peptide-Radioisotope Drug Conjugates
2023-09-27
AcuraStem and Takeda Collaborate on Innovative ALS Treatment
2023-09-27
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
2023-09-27
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top